Trial Profile
The efficacy for type 2 diabetes of repaglinide taking twice or three times a day
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Sep 2012 Actual initiation date changed from 1 Jan 2012 to 15 Jul 2011 as reported by University Hospital Medical Information Network - Japan.
- 14 Sep 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 16 Dec 2011 New trial record